fluoxetine has been researched along with lysophosphatidylcholines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ask, KS; Bardakci, T; Gjelstad, A; Halvorsen, TG; Parmer, MP; Pedersen-Bjergaard, S; Øiestad, EL | 1 |
| Ahmadi, M; Alipour, M; Chehelcheraghi, F; Gholami, E; Gholami, MR; Khaksarian, M; Rezaian, J; Tavakoli, A | 1 |
2 other study(ies) available for fluoxetine and lysophosphatidylcholines
| Article | Year |
|---|---|
Parallel artificial liquid membrane extraction as an efficient tool for removal of phospholipids from human plasma.
Topics: Chromatography, Liquid; Fluoxetine; Fluvoxamine; Humans; Lysophosphatidylcholines; Membranes, Artificial; Pharmaceutical Preparations; Phosphatidylcholines; Phospholipids; Plasma; Quetiapine Fumarate; Sphingomyelins; Tandem Mass Spectrometry; Technology, Pharmaceutical | 2016 |
Effect of fluoxetine treatment on neurotoxicity induced by lysolecithin in male rats.
Topics: Animals; Brain-Derived Neurotrophic Factor; Corpus Callosum; Demyelinating Diseases; Disease Models, Animal; Fluoxetine; Forkhead Transcription Factors; Gene Expression; Lysophosphatidylcholines; Male; Myelin Basic Protein; NF-kappa B; Nitric Oxide Synthase; Oligodendrocyte Transcription Factor 2; Rats, Wistar; Tumor Necrosis Factor-alpha | 2022 |